Article
Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.
Journal of hematology & oncology - 14 Jun 2015
Tzankov Alexandar, Leu Nora, Muenst Simone, Juskevicius Darius, Klingbiel Dirk, Mamot Christoph, Dirnhofer Stephan
Abstract excerpt
BACKGROUND: The prognostic role of tumor-related parameters in diffuse large B cell lymphoma (DLBCL) is a matter of controversy. METHODS: We investigated the prognostic value of phenotypic and genotypic profiles in DLBCL in clinical trial (NCT00544219) patients homogenously treated with six cycles of rituximab, cyclophosphamide, hydroxydaunorubicin, vincristine, prednisone (R-CHOP), followed by two cycles of R...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.